tirzepatide alternatives 2025 https://investor.lilly.com/news-releases/news-release-details/zepbound- tirzepatide-most-prescribed-weight-management “Eli Lilly and Company (NYSE: LLY) today announced the U.S. Food and Drug Administration (FDA) approved a label expansion for Zepbound What's Next? : r/tirzepatidecompound

Contraindications: BPC-157 therapy is not appropriate for patients with active cancer, during pregnancy or breastfeeding, or for those on blood thinners (anticoagulants) without provider clearance

Early research suggests that increasing glutathione levels may strengthens your immune response against bacteria and viruses

Tirzepatide takes it a step further by targeting two hormones, GLP-1 and GIP, offering stronger appetite control along with improved metabolism and fat burning

At Fitty , we believe lasting weight management starts with sustainable habits, supported by science-backed nutrition designed to fit into everyday life